osteolabs

osteolabs Publishes First Real-World Evidence Data from Close to 3,000 OsteoTest Patient Samples

First report on the application of CIM (Calcium isotope marker) technology in serum and urine demonstrating excellent correlation of CIM with all metabolic diseases, therapies, and diets affecting musculoskeletal metabolism 15 August 2024 -- Kiel, Germany -- osteolabs GmbH, an innovative diagnostic company applying its proprietary CIM (Calcium isotope marker) technology for the early detection of...

Osteolabs to Present New Clinical Data from Over 2,400 OsteoTest Routine Samples at the WCO-IOF-ESCEO Congress

New data fully supporting potential for OsteoTest to qualify as new universal diagnostic method for early osteoporosis risk assessment and therapeutic control 9 April 2024 -- Kiel, Germany -- Osteolabs, an innovative diagnostic company applying its proprietary CIM (calcium isotope marker) technology for the early detection of calcium-related metabolic bone diseases affecting over 1 billion...
5 Bisham Court Marlow SL7 1SD UK

+44 1628 947946